Articles tagged "Kidney/pancreas transplantation"

2018 American Transplant Congress
Rejection and Graft Loss in Patients with BK Viremia after Simultaneous Pancreas and Kidney Transplant
D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas, R. Kandaswamy.
University of Minnesota, Minneapolis, MN.
Background: BK virus is a recognized cause of kidney allograft dysfunction. The treatment of BK is immunosuppression reduction. This reduction in patients with a simultaneous…
2018 American Transplant Congress
BK Viremia in Simultaneous Kidney Pancreas Recipients: Single Center Experience
M. Alebrahim,¹ R. Pelletier,¹ A. Rajab,¹ G. Bumgardner,¹ R. Daloul,² C. Akateh,³ K. Washburn,¹ A. El-Hinnawi.¹
¹Transplant Surgery, The Ohio State University Wexner Medical Center, Columbus, OH; ²Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH; ³Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Introduction: The impact of BK viremia in recipients of simultaneous pancreas and kidney transplantation (SPK) is not well known. We therefore studied the incidence and…
2018 American Transplant Congress
Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study
N. Singh, A. Pulisetty, D. Aultman, R. McMillan, G. Zibari, H. Shokouh-Amiri.
LSU, Shreveport, LA.
BACKGROUND: A UNOS/OPTN policy approved in 2015 allowed simultaneous pancreas-kidney transplants (SPK) for type-2 diabetic patients. We examined the effect of this policy on volume…
2018 American Transplant Congress
Analyzing Transplant Medication Myths
R. Krislock, J. Brandenberger, P. Stracener, A. Weiss, K. Wipperling, C. Kuhr.
Division of Transplant, Virginia Mason Medical Center, Seattle, WA.
Patients may misconstrue the amount of medications required for transplantation, expecting to take “handfuls” of medications for life. This study aims to determine the change…
2018 American Transplant Congress
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation
N. Garg, T. Ellis, R. Redfield, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.
University of Wisconsin, Madison.
Third party ABO-compatible vessel allografts (VA) are sometimes used as extension vessels for kidney and pancreas transplants (TX). The frequency and implications of de novo…
2018 American Transplant Congress
Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results
M. Spaggiari,¹ C. Di Bella,¹ P. Di Cocco,¹ F. Gheza,¹ E. Benedetti,¹ I. Tzvetanov,¹ J. Oberholzer.²
¹Surgery, University of Illinois, Chicago, IL; ²Surgery, University of Virginia, Virginia, VA.
IntroductionObesity is considered a relative contraindication to pancreas transplantation due to increased risks of wound and surgical related complications. Robotic surgery has never been applied…
2018 American Transplant Congress
Declining Number of Pancreas after Kidney Transplants Despite Significant Improvement in Outcome
A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
¹SUNY Downstate Medical Center, Brooklyn, NY; ²SUNY Upstate Medical University, Syracuse, NY.
Introduction: The number of whole organ pancreas transplants declined significantly over the past 15 years. The largest decrease was seen in pancreas after kidney (PAK)…
2017 American Transplant Congress
Pregnancy After Kidney-Pancreas Transplantation: Maternal and Offspring Outcomes.
S. Rao,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^1,2 M. Moritz.^2,3,4
¹Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA; ²Gift of Life Institute, Transplant Pregnancy Registry International, Philadelphia, PA; ³Surgery, Lehigh Valley Health Network, Allentown, PA; ⁴Morsani College of Medicine, USF, Tampa
This study analyzed 109 pregnancies (116 outcomes) in 62 female kidney-pancreas (KP) recipients reported to the Transplant Pregnancy Registry International (TPR). Data were collected via…
2017 American Transplant Congress
Type 1 Diabetic Patients Have Better Endothelial Function After Simultaneous Pancreas-Kidney Transplantation Than After Kidney Transplantation with Continued Insulin Therapy.
A. Kolonko,² A. Kowalik,¹ J. Ziaja,¹ D. Kaminska,³ A. Owczarek,⁴ A. Kujawa-Szewieczek,² M. Kusztal,³ J. Badura,¹ D. Bozek-Pajak,¹ A. Zakrzewska,⁵ P. Choreza,⁴ R. Krol,¹ S. Chlopicki,⁵ M. Klinger,³ A. Wiecek,² J. Chudek,⁶ L. Cierpka.¹
¹Medical University of Silesia, Katowice, Poland; ²Medical University of Silesia, Katowice, Poland; ³Wroclaw Medical University, Wroclaw, Poland; ⁴Medical University of Silesia, Sosnowiec, Poland; ⁵Jagiellonian University, Krakow, Poland; ⁶Medical University of Silesia, Katowice, Poland
Objective: The improvement of blood glucose metabolism in type 1 diabetic (T1D) patients after simultaneous pancreas-kidney transplantation (SPK) is anticipated to slow progression of vascular…
2017 American Transplant Congress
Donor Age Is the Most Important Predictor of Longterm Graft Function in Simultaneous Pancreas-Kidney Transplantation from Donors After Cardiac Death.
J. Chen,¹ D. Mikhail,^1,2 H. Sharma,³ A. Hijazi,¹ D. Nap,¹ L. Stitt,⁴ J. Jevnikar,⁵ M. Cooper,⁶ P. Luke,^1,2 A. Sener.^1,2
¹Schulich School of Medicine and Dentistry, London, Canada; ²Division of Urology, Department of Surgery, Western University, London, London, Canada; ³Division of General Surgery, Department of Urology, Western University, London, Canada; ⁴LW Stitt Statistical Services, London, Canada; ⁵Faculty of Engineering and Architectural Sciences, Ryerson University, Toronto, Canada; ⁶Georgetown University, Washington
STUDY PURPOSE: We analyzed data from UNOS to determine the effects of donor age, donor BMI, and organ cold ischemic time on DCD-SPK graft outcomes.METHODS:…